Labeled antibiotics: Positron tomography as a tool for measuring tissue distribution

Drug Development Research

Volumn 59, Issue 2, 2003, Pages 261-268

  Tewson, T J ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b 0911Z JPP   (United States)

Author keywords

Carbon 11; Erythromycin; Fluorine 18; Fluoroquinolines

Indexed keywords

ANTIBIOTIC AGENT; BLEOMYCIN; BLEOMYCIN CO 55; CARBON 11; DIAZOMETHANE C 11; ERYTHROMYCIN C 11; ERYTHROMYCIN LACTOBIONATE; FLEROXACIN; FLEROXACIN F 18; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; INDIUM 111; LOMEFLOXACIN; LOMEFLOXACIN F 18; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TROVAFLOXACIN; TROVAFLOXACIN F 18; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CLINICAL TRIAL; CREUTZFELDT JAKOB DISEASE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG LABELING; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRON TRANSPORT; HUMAN; ISOTOPE LABELING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; REACTION ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0041846487     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10224     Document Type: Article

References (35)

1. 18F-labeling and biodistribution of the novel fluoro-quinolone antimicrobial agent, trovafloxacin (CP 99,219). Nuel Med Biol 23:995-998.
2. Becker W, Meller J. 2001. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis 1:326-333.
3. Britton KE, Vinjamuri S, Hall AV, Solanki K, Siraj QH, Bomanji J, Das S. 1997. Clinieal evaluation of technetium-99m infecton for the localisation of baeterial infection. Eur J Nucl Med 24:553-556.
4. De Winter F, Vogelaers D, Gemmel F, Dierckx RA. 2002. Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases. Eur J Clin Microbiol Infect Dis 21:247-257.
5. Elsinga PH, Franssen EJ, Hendrikse NH, Fluks L, Weemaes AM, van der Graaf WT, de Vries EG, Visser GM, Vaalburg W. 1996. Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET. J Nucl Med 37:1571-1575.
6. Engler H, Lundberg PO, Ekbom K, Nennesmo I, Nilsson A, Bergstrom M, Tsukada H, Hartvig P, Langstrom B. 2003. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease. Eur J Nucl Med Mol Imag 30:85-95.
7. 11C]daunorubiein for functional imaging of P-glycoprotein with PET. Appl Radiat Isot 49:811-813.
8. 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography. Antimicrob Agents Chemother 36:2286-2292.
9. 18F]fleroxacin in healthy human subjects studied by using positron emission tomography. Antimicrob Agents Chemother 37:2144-2152.
10. 18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography. Antimicrob Agents Chemother 40:659-664.
11. 18F]trovafloxacin in healthy human subjects studied with positron emission tomography. Antimicrob Agents Chemother 42:2048-2054.
12. 18F]-2-fluoro-deoxyglucose. J Comput Assist Tomogr 8:978-981.
13. 99mTc-Infecton, a novel agent for detecting sites of infection. J Clin Pathol 51:215-219.
14. Jekunen AP, Kairemo KJ, Ramsay HA, Kajanti MJ. 1996. Imaging of olfactory neuroblastoma by In-111 bleomycin complex. Clin Nucl Med 21:129-131.
15. 99mTe-ciprofloxacin (Infecton) imaging in the diagnosis of knee prosthesis infections. Nucl Med Commun 23:167-170.
16. 18F-labeled fleroxacin. Nucl Med Biol 20:81-87.
17. Mamo L, Nouel JP, Robert J, Chai N, Houdart R. 1973. Use of radioactive bleomycin to detect malignant intracranial tumors. Comparative study with technetium-99m in 104 cases. J Neurosurg 39:735-741.
18. Paton JH, Reeves DS. 1988. Flnoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use. Drugs 36:193-228.
19. Peters AM. 1998. The use of nuclear medicine in infections. Br J Radiol 71:252-261.
20. Pike WP, Palmer AJ. 1982. Preparation of a carbon-11 labelled antibiotic, erythromycin A lactobionate. J Chem Soc Chem Comnun 1982:173-174.
21. 57Co. Eur J Nucl Med 4:191-197.
22. 18F]fleroxacin. Am J Med 94:31S-37S.
23. Sharma H, Zweit J, Smith AM, Downey S. 1986. Production of cobalt-55, a short-lived, positron emitting radiolabel for bleomycin. Int J Rad Appl Instrum [A] 37:105-109.
24. Sharma R, Mondal A, Sharma M, Popli M, Chopra MK, Sawroop K, Kashyap R. 2001. Tc-99m Infecton scan in possible pelvic inflammatory disease. Clin Nucl Med 26:208-211.
25. Sharma R, Mondal A, Chopra MK, Rawat HS, Kashyap R. 2002. Tc-99m infecton and Tc-99m MDP imaging in osteomyelitis of the hip joint. Clin Nucl Med 27:217-218.
26. Shen LL, Baranowski J, Pernet AG. 1989a. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: specificity and cooperativity of drug binding to' DNA.' Biochemistry 28:3879-3885.
27. Shen LL, Kohlbrenner WE, Weigl D, Baranowski J, 1989b. Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes, J Biol Chem 264:2973-2978.
28. Shen LL, Mitscher LA, Sharma PN, O'Donnell TJ, Chu DW, Cooper CS, Rosen T, Pernet AG. 1989c. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug - DNA binding model. Biochemistry 28:3886-3894.
29. 99mTc-HMPAO leukocyte scintigraphy. J Nucl Med 42:567-574.
30. Tewson TJ, Yang D, Wong G, Macy D, DeJesus OJ, Nickles RJ, Perlman SB, Taylor M, Frank P. 1996. The synthesis of fluorine-18 lomefloxacin and its preliminary use in human studies. Nucl Med Biol 23:767-772.
31. 99mTc infection imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection, Lancet 8312:233-235.
32. Wollmer P, Pride NB, Rhodes CG, Sanders A, Pike WW, Palmer AJ, Silvester DJ, Liss RH. 1982. Measurement of pulmonary erythromycin concentration in patients with lobar pneumonia means of positron tomography. Lancet means 8996:1361-1364.
33. Yapar Z, Kibar M, Yapar AF, Togrul E, Kayaselcuk U, Sarpel Y. 2001. The efficacy of technetium-99m ciprofloxacin (Infecton) imaging in suspected orthopaedic infection: a comparison with sequential bone/gallium imaging. Eur J Nucl Med 28:822-830.
34. 18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 35:1773-1782.
35. 18F-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflamation. Semin Nucl Med 32:47-59.